About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

High Doses of Antidepressants Increase Suicidal Risk in Children, Young Adults

by Bidita Debnath on April 29, 2014 at 11:41 PM
Font : A-A+

High Doses of Antidepressants Increase Suicidal Risk in Children, Young Adults

Young adults and children who start antidepressant therapy at high doses, rather than the prescribed doses, appear to be at greater risk for suicidal behavior during the first 90 days of treatment, reveals a new study.

Author: Matthew Miller, M.D., Sc.D., of the Harvard School of Public Health, Boston, and colleagues.

Advertisement

Background: A previous meta-analysis by the U.S. Food and Drug Administration (FDA) of antidepressant trials suggested that children who received antidepressants had twice the rate of suicidal ideation and behavior than children who were given a placebo. The authors of the current study sought to examine suicidal behavior and antidepressant dose, and whether risk depended on a patient's age.

How the Study Was Conducted: The study used data from 162,625 people (between the ages of 10 to 64 years) with depression who started antidepressant treatment with a selective serotonin reuptake inhibitor at modal (the most prescribed doses on average) or at higher than modal doses from 1998 through 2010.
Advertisement

Results: The rate of suicidal behavior (deliberate self-harm or DSH) among children and adults (24 years or younger) who started antidepressant therapy at high doses was about twice as high compared with a matched group of patients who received generally prescribed doses. The authors suggest this corresponds to about one additional event of DSH for every 150 patients treated with high-dose therapy. For adults 25 to 64 years old, the difference in risk for suicidal behavior was null. The study does not address why higher doses might lead to higher suicide risk.

Discussion: "Considered in light of recent meta-analyses concluding that the efficacy of antidepressant therapy for youth seems to be modest, and separate evidence that dose is generally unrelated to the therapeutic efficacy of antidepressants, our findings offer clinicians an additional incentive to avoid initiating pharmacotherapy at high-therapeutic doses and to monitor all patients starting antidepressants, especially youth, for several months and regardless of history of DSH."

(JAMA Intern Med. Published online April 28, 2014. doi:10.1001/jamainternmed.2014.1053. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor's Note: Authors made a conflict of interest and funding disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Commentary: Initial Dose of Antidepressants, Suicidal Behavior in Youth

In a related commentary, David A. Brent, M.D., of the University of Pittsburgh, and Robert Gibbons, Ph.D., of the University of Chicago, write: "In summary Miller et al are to be commended on a thoughtful and careful analysis of the effects of initiating antidepressants at higher than modal doses."

"Their findings suggest that higher than modal initial dosing leads to an increased risk for DSH and adds further support to current clinical recommendations to begin treatment with lower antidepressant doses. While initiation at higher than modal doses of antidepressants may be deleterious, this study does not address the effect of dose escalation," they continue.

"Moreover, while definitive studies on the impact of dose escalation in the face of nonresponse remain to be done, there are promising studies that suggest in certain subgroups, dose escalation can be of benefit. Finally it should be noted that in this study, there was no pre-exposure to post-exposure increase in suicidal behavior after the initiation of antidepressants in youth treated at the modal dosage," they conclude.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Health Benefits of Sea Buckthorn
Contraceptive Pills in Polycystic Ovary Syndrome (PCOS) Curtail Type 2 Diabetes Risk
Mushroom May Help Cut Down the Odds of Developing Depression
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Antidepressants Antidepressants Use during Pregnancy 

Recommended Reading
Good Medical Provider Communication Improves Antidepressant Adherence for Diabetes Patients
Adult diabetes patients who trust their medical provider and feel included in treatment decisions .....
Antidepressant Effect of Seroxat Enhanced by Acupuncture
Previous research has shown that acupuncture is more effective than oral antidepressants in ......
Strong Evidence Shown for a New Class of Antidepressant Drugs
For the first time, scientists have shown that a chemical in the brain called galanin is involved .....
Study Questions Speed in Giving Antidepressants to Grieving Parents
Some doctors are too quick to prescribe antidepressants to parents who have suffered the death of a ...
Antidepressants Use during Pregnancy
Depression is common during pregnancy and antidepressants are usually prescribed to overcome it. Is ...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use